PHAT — Phathom Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- $537.25m
- $600.63m
- $0.68m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 244 | 287 | 183 | 155 | 381 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | — | — | 1.64 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 256 | 291 | 187 | 161 | 397 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.4 | 3.36 | 2.56 | 3.49 | 3.62 |
Other Long Term Assets | |||||
Total Assets | 257 | 295 | 189 | 165 | 414 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.75 | 55.5 | 18.9 | 26.2 | 38.8 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 29.2 | 101 | 117 | 240 | 487 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 228 | 194 | 72.2 | -74.8 | -72.8 |
Total Liabilities & Shareholders' Equity | 257 | 295 | 189 | 165 | 414 |
Total Common Shares Outstanding |